South Korea Resectoscope Devices Market Size, Share, and COVID-19 Impact Analysis, By Device Type (Monopolar Resectoscopes and Bipolar Resectoscopes), By Application (Urology, Gynecology, and General Surgery), and South Korea Resectoscope Devices Market Insights, Industry Trend, Forecasts to 2035
Industry: HealthcareSouth Korea Resectoscope Devices Market Size Insights Forecasts to 2035
- The South Korea Resectoscope Devices Market Size Was Estimated at USD 5.76 Million in 2024
- The Market Size is Expected to Grow at a CAGR of around 5.26%from 2025 to 2035
- The South Korea Resectoscope Devices Market Size is Expected to Reach USD 10.12 Million by 2035
Get more details on this report -
According to a research report published by Spherical Insights & Consulting, the South Korea Resectoscope Devices Market Size is anticipated to reach USD 10.12 million by 2035, growing at a CAGR of 5.26% from 2025 to 2035. The growing elderly population base, evolving healthcare infrastructure, rising prevalence of urogenital disorders, and technological improvements are the main drivers of market growth. The number of problems requiring surgery is increasing due to the world's aging population.
Market Overview
The industry that produces, distributes, and sells resectoscopes surgical tools used for tissue resection and removal from various bodily areas such the uterus, prostate, bladder, or urethra is included in the market for resectoscope devices. These are endoscope-like devices with instruments for manipulating tissue and a camera for visualization. The rising incidence of urogenital disorders and improvements in surgical technology are driving the market. Resectoscopes make it possible to remove tissue through tiny incisions or naturally occurring bodily apertures, which minimizes tissue damage, lessens pain, and speeds up healing. The resectoscope's built-in camera and light source give doctors a clear, enlarged picture of the surgical site, facilitating accurate tissue removal and lowering the possibility of problems. The adoption of resectoscopes is the growing desire for minimally invasive operations, which are supported by advantages including quicker recovery and less scarring. The increasing prevalence of urological conditions such as benign prostatic hyperplasia (BPH) is fueling the need for resectoscopes.
Report Coverage
This research report categorizes the market for South Korea resectoscope devices market based on various segments and regions forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea resectoscope devices market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment South Korea resectoscope devices market.
South Korea Resectoscope Devices Market Report Coverage
Report Coverage | Details |
---|---|
Base Year: | 2024 |
Market Size in 2024: | USD 5.76 Million |
Forecast Period: | 2025-2035 |
Forecast Period CAGR 2025-2035 : | 5.26% |
2035 Value Projection: | USD 10.12 Million |
Historical Data for: | 2020-2023 |
No. of Pages: | 136 |
Tables, Charts & Figures: | 128 |
Segments covered: | By Device Type, By Application and COVID-19 Impact Analysis |
Companies covered:: | SPL Life Sciences Co., Ltd., Human Corporation, Young Lin Instrument Co., Ltd., SAMWOO S&T Co., Ltd., Ahram Biosystems, Inc., Bioneer Corporation, Curiosis Inc., Genesystem Co., Ltd., Laminar Co., Ltd., Seegene, Inc., and Other key vendors |
Pitfalls & Challenges: | COVID-19 Impact, Challenges, Future, Growth, & Analysis |
Get more details on this report -
Driving Factors
The rising prevalence of urogenital and gynecological conditions such as BPH, bladder tumors, and uterine fibroids driven by aging reginal populations and lifestyle-related health trends. The shift toward minimally invasive procedures offered by modern resectoscopes delivers faster recovery, reduced complications, and shorter hospital stays, boosting adoption. Technological innovations, like high-definition optics, bipolar and plasma modalities, and ergonomic hybrid designs, enhance procedural precision and safety.
Restraining Factors
The high cost of advanced devices and surgical procedures, limiting access in low- and middle-income countries. Lack of skilled professionals trained in minimally invasive techniques further restricts adoption. Additionally, risks of complications such as bleeding, infection, or injury to surrounding organs can deter patients and surgeons. Strict regulatory approvals and lengthy clinical validation timelines also delay product launches.
Market Segmentation
The South Korea resectoscope devices market share is classified into device type and application.
- The biopolar resectoscopes segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.
The South Korea resectoscope devices market is segmented by device type into monopolar resectoscopes and bipolar resectoscopes. Among these, the bipolar resectoscopes segment held a significant share in 2024 and is expected to grow at a substantial CAGR during the forecast period. The use of saline irrigation in ipolar systems considerably lowers the risk of transurethral resection syndrome (TUR syndrome), a potentially fatal consequence linked to the absorption of non-isotonic irrigation fluids. Bipolar resectoscopes are appropriate for patients who already have cardiovascular or renal disorders because of this feature.
- The urology segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.
The South Korea resectoscope devices market is segmented by application into urology, gynecology, and general surgery. Among these, the urology segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. Transurethral resection of the prostate (TURP) and transurethral resection of bladder tumors (TURBT), which are the mainstay treatments for bladder cancer and benign prostatic hyperplasia (BPH), respectively, are two procedures that use resectoscope devices.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the South Korea resectoscope devices market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the companies' current news and developments, including product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
List of Key Companies
- SPL Life Sciences Co., Ltd.
- Human Corporation
- Young Lin Instrument Co., Ltd.
- SAMWOO S&T Co., Ltd.
- Ahram Biosystems, Inc.
- Bioneer Corporation
- Curiosis Inc.
- Genesystem Co., Ltd.
- Laminar Co., Ltd.
- Seegene, Inc.
- Others
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea resectoscope devices market based on the below-mentioned segments:
South Korea Resectoscope Devices Market, By Device Type
- Monopolar Resectoscopes
- Bipolar Resectoscopes
South Korea Resectoscope Devices Market, By Application
- Urology
- Gynecology
- General Surgery
Need help to buy this report?